2013
$239M
from 35 investors over 35 rounds
Recursion Pharmaceuticals raised $150M on October 25, 2022
Investors: Laurion Capital Management LP, Baillie Gifford and The Invus Group
Recursion Pharmaceuticals raised $239M on September 9, 2020
Investors: Laurion Capital Management LP, Two Sigma Ventures, Intermountain Ventures, Obvious Ventures, Samsara BioCapital, Felicis Ventures, Lux Capital and Leaps by Bayer
Recursion Pharmaceuticals raised $121M on July 15, 2019
Investors: Obvious Ventures, Felicis Ventures, Lux Capital, Two Sigma Ventures, Menlo Ventures and University of Minnesota
Recursion Pharmaceuticals raised undisclosed on February 8, 2019
Investors: GRIDS Capital
Recursion Pharmaceuticals raised $21M on June 5, 2018
Investors: Square 1 Bank
Recursion Pharmaceuticals raised $546K on May 7, 2018
Investors: Bill & Melinda Gates Foundation
Recursion Pharmaceuticals raised undisclosed on February 12, 2018
Investors: Advantage Capital and Necessary Ventures
Recursion Pharmaceuticals raised $60M on October 4, 2017
Investors: Menlo Ventures, Lux Capital, Felicis Ventures, Obvious Ventures, Two Sigma Ventures, CRV and Data Collective
Recursion Pharmaceuticals raised $4M on February 7, 2017
Investors: Square 1 Bank
Recursion Pharmaceuticals raised $2.2M on November 22, 2016
Investors: Data Collective, Lux Capital, AME Cloud Ventures, Felicis Ventures and Obvious Ventures